We suspect some of these interacting residues will also be found in human diseases, given the large number of mutations that have been found present in various cancer types for METTL11A, METTL11B, and METTL13 (37), which could possibly be eliciting problematic effects through the disruption of their noncatalytic functions. This evidence concerns the gene METTL13 and cancer.